Posted in | News

Prototype Raman Probe Wins European Prize

A new fibre probe, which uses Raman spectroscopy to identify cancer cells, has scooped top prize in the recent Photonics21 'Prototype your Idea' competition.

Research student Calum Ross from Heriot-Watt University, Scotland, working with Heriot-Watt Professor Robert Thomson, and Brian Smith and Nick Weston from Renishaw plc, has developed an innovative method to assess cells for oesophageal cancer without the need for painful biopsies. Using a technique known as optical biopsy, the probe would be used during an endoscopy to provide instantaneous diagnostic feedback to the clinician. This is a promising technology for the future of medical testing with the potential to be used for multiple applications.

We've targeted the oesophagus in this project but in fact any tissue or organ accessible via endoscope or hypodermic needle can be analysed.

Calum Ross, Research Student, Heriot-Watt University

During a Raman-based optical biopsy, light is delivered onto suspect tissue via optical fibres where it interacts with molecules in the tissue to generate a molecular fingerprint. This molecular fingerprint can then be used to differentiate healthy and cancerous tissue in real-time. Calum has developed a novel Raman probe which is used to deliver and collect the light signal efficiently, along with an advanced direct laser writing method which will enable the probe to be mass produced.

The Prototype your Idea competition is run by Photonics21, a 2,500 strong membership organisation that unites the majority of Europe's leading photonics industries and relevant R&D stakeholders. The competition, which supports talented makers and students who have a real interest in becoming entrepreneurs by combining creativity with photonics, is supported by Knowledge Transfer Network and ACTPHAST - a one-stop shop rapid prototyping incubator for supporting photonics innovations by European companies.

As well as a €5,000 cash prize, Calum and the team will also receive €30,000 worth of support from the ACTPHAST hub to help develop the probe for mass production. The fibre probe technology lends itself well to commercialisation.

The raw materials used to make the probe are inexpensive and the probe manufacture could be automated for mass production. The support from ACTPHAST could prove extremely valuable in taking the probe from lab bench to pre-production prototype.

Calum Ross, Research Student, Heriot-Watt University

For further information on the world of Raman, visit


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Renishaw plc - Spectroscopy. (2019, August 14). Prototype Raman Probe Wins European Prize. AZoM. Retrieved on February 28, 2024 from

  • MLA

    Renishaw plc - Spectroscopy. "Prototype Raman Probe Wins European Prize". AZoM. 28 February 2024. <>.

  • Chicago

    Renishaw plc - Spectroscopy. "Prototype Raman Probe Wins European Prize". AZoM. (accessed February 28, 2024).

  • Harvard

    Renishaw plc - Spectroscopy. 2019. Prototype Raman Probe Wins European Prize. AZoM, viewed 28 February 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.